|Ticker||Company||Sector||% Price Change Past 10 Days||Previous Close||TradingView Rating|
|CAPR||Capricor Therapeutics Inc.||Healthcare & Biotech||+38%||$5.31||Buy|
|ENTX||Entera Bio Ltd.||Healthcare & Biotech||+25%||$4.42||Buy|
- TradingView’s 1 Day Technical Analysis chart has both CAPR and ENTX rated as a Buy
- Zacks has both CAPR and ENTX listed within the Bottom 23% in their Industry Rankings and CAPR rated as a Hold, while ENTX is rated a SELL
- TipRanks.com has both CAPR and ENTX rated as Moderate Buys. Join TipRanks.com to get all the Strong Buys, Inside Trades and more...
- Yahoo! Finance has both CAPR and ENTX showing a Bullish short-term Outlook
- Barchart has ENTX rated as a Strong Buy but CAPR as a Weak Buy